Amgen | AMGN - Pre Tax Profit

Stock Price
326.37
Daily Change
-19.88 -5.74%
Monthly
-6.20%
Yearly
16.06%
Q2 Forecast
337.18

Amgen reported $1.51B in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
AbbVie USD 5.57B 2.9B Mar/2026
Agios Pharmaceuticals USD -99.11M 9.94M Mar/2026
ALKERMES USD 100.74M 4.1M Sep/2025
Amgen USD 1.51B 2.41B Dec/2025
Biogen USD 377.7M 433.7M Mar/2026
BioMarin Pharmaceutical USD -26.32M 324.19M Sep/2025
Bristol-Myers Squibb USD 1.47B 1.64B Dec/2025
Coherus Biosciences USD -46.35M 90.86M Dec/2025
Eli Lilly USD 8.27B 1.03B Dec/2025
Exelixis USD 252.69M 275K Dec/2025
Genmab DKK 55M 427M Dec/2025
Gilead Sciences USD 2.08B 1.56B Dec/2025
GlaxoSmithKline GBP 2.14B 919M Mar/2026
Glaxosmithkline GBP 2.46B 569M Sep/2025
Incyte USD 389.94M 92.37M Dec/2025
Ionis Pharmaceuticals USD -93M 135M Mar/2026
J&J USD 7.82B 2.86B Mar/2026
Merck USD 3.42B 3.32B Dec/2025
Moderna USD -799M 612M Dec/2025
Neurocrine Biosciences USD 239.4M 52.4M Dec/2025
Novartis USD 4.64B 445M Dec/2025
Novartis USD 5.17B 637M Sep/2025
Pfizer USD 3.33B 290M Sep/2025
PTC Therapeutics USD -139.08M 116.01M Dec/2025
Puma Biotechnology USD 20.61M 24.76M Sep/2024
Regeneron Pharmaceuticals USD 1.04B 719.6M Dec/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Sanofi EUR -1.16B 5.5B Dec/2025
Sarepta Therapeutics USD -407.67M 213.63M Dec/2025
Takeda JPY 133.86B 105.69B Dec/2025
Teva Pharmaceutical Industries USD 753M 662M Mar/2026
Ultragenyx Pharmaceutical USD -128M 51.54M Dec/2025
Vertex Pharmaceuticals USD 1.3B 15.8M Sep/2025